AzTrials
AzTrials

Nutritional SupportNCT02763904

Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients At Nutritional Risk

A study testing Intensive nutritional counseling and Dietary counseling in people with Nutritional Support, run by Emanuele Cereda at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Protein-calorie malnutrition is a frequent comorbidity in hospitalized patients and there is evidence that the nutritional status may influence the response to drug treatment, mortality, susceptibility to infections, the patient's functional status, duration of hospital stay and, consequently, overall healthcare… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Nutritional Support
What is being tested?
Intensive nutritional counseling and Dietary counseling
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
1 siteItaly
Study dates
30 Jul 2016to 30 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Nutritional Risk Score [NRS-2002] ≥3
  • assessed within 48 hours since admission
  • expected length of stay ≥7 days
  • written informed consent

Who cannot join

  • age < 18 years
  • ongoing or indication to artificial nutrition
  • severe hypophagia (intake <50% of estimated requirements)
  • scheduled for surgery
  • indication to fasting
  • physician-based contra-indication to use of liquid oral nutritional supplements (vomitus, severe nausea, diarrhea, dysphagia)
Show all 9Show fewer
  • physician-based indication to the of disease-specific oral nutritional supplements (e.g. kidney failure or pressure ulcers)
  • terminal illness
  • unavailability to planned measurements

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo

    Pavia, 27100

Other trials in Italy

About this study

Official title: Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients At Nutritional Risk Receiving Dietary Counseling: a Randomized, Controlled Trial

Protein-calorie malnutrition is a frequent comorbidity in hospitalized patients and there is evidence that the nutritional status may influence the response to drug treatment, mortality, susceptibility to infections, the patient's functional status, duration of hospital stay and, consequently, overall healthcare costs. The causes of malnutrition are manifold. The underlying disease may in fact lead to an increase in the patient's energy needs, whether or not associated with a reduction in caloric intake. The same therapeutic treatments can further worsen the energy balance without considering that the patient can be kept fasting for the execution of some diagnostic procedures. Therefore, a further deterioration of nutritional status during hospitalization could occur.

International guidelines underline the utility to set a nutritional support whenever this is necessary, not only to prevent or treat malnutrition but also improve clinical outcomes. In this perspective, the improvement of oral diet and the use of oral nutritional supplements (ONS) represent the first-line strategy of intervention. Previous studies have shown that nutritional counseling, with or without the use of ONS, in patients with chronic disease is able to improve the calorie-protein intake, prevent deterioration of nutritional status, as well as to increase to a certain extent body weight. Particularly, energy-dense are more effective in increase energy intake. These data have highlighted the importance of a proper evaluation of the nutritional status of early detection of patients who could benefit of nutritional support. However, the independent role of the ONS in improving clinical outcome still needs to be established.

Being tested
Intensive nutritional counseling, Dietary counseling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive nutritional counselingDietary supplement

    Dietary counseling + energy-dense oral nutritional supplements since admission

  • Dietary counselingOther

    Dietary counseling alone. In case of inadequate energy intake patients will receive oral nutritional supplements since day 8 from admission (after the evaluation of the primary end point)

Study groups in NCT02763904
Study groupRoleWhat they receive
Intensive nutritional counselingExperimentalDietary counseling + energy dense oral nutritional supplements
Receives: Dietary Supplement: Intensive nutritional counseling
Dietary counselingActive comparatorDietary counseling
Receives: Other: Dietary counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Body composition

    Change in phase angle as assessed by vectorial impedance analysis

    Measured: 7 days

Secondary outcomes (9)
  1. Body composition

    Change in phase angle as assessed by vectorial impedance analysis

    Measured: 14 days

  2. Body composition

    Change in phase angle as assessed by vectorial impedance analysis

    Measured: Hospital stay, an average of 17 days

  3. Functional status

    Change in handgrip strength as assessed by dynamometry

    Measured: 7 days

  4. Functional status

    Change in handgrip strength as assessed by dynamometry

    Measured: 14 days

  5. Functional status

    Change in handgrip strength as assessed by dynamometry

    Measured: Hospital stay, an average of 17 days

  6. Energy intake

    Protein-calorie intake as assessed by serial 24-hour dietary recall

    Measured: 7 days

  7. Energy intake

    Protein-calorie intake as assessed by serial 24-hour dietary recall

    Measured: 14 days

  8. Infections

    Incidence of new infections during the hospital stay

    Measured: Hospital stay, an average of 17 days

  9. Adverse events

    Gastrointestinal intolerance events

    Measured: Hospital stay, an average of 17 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2016 (estimated)
  2. Study start30 Jul 2016
  3. Primary completion24 Jul 2024
  4. Study completion30 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02763904
Sponsor's protocol ID
20150005564
Status last verified
Nov 2024
First submitted
3 May 2016
Last updated
18 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Intensive nutritional counseling and Dietary counseling in people with Nutritional Support, run by Emanuele Cereda at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Body composition (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in